DIPROPHOS

This brand name is authorized in Austria, Estonia, Poland, Romania

Active ingredients

The drug DIPROPHOS contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone disodium phosphate UNII 7BK02SCL3W - BETAMETHASONE SODIUM PHOSPHATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB01	Betamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1206324, 1732047
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100019456
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68208001, W68208002